New Medical Devices In The Market Essay

PAGES
2
WORDS
718
Cite
Related Topics:

Medical Devices The Bleeding Edge is a Netflix film that examines the $400 billion medical device industry, which produces and markets highly complex apparatuses that are implanted into human bodies (Dick, 2018). The documentary was carried out on the premise that more than 70 million Americans have been outfitted with internal medical devices. While there are numerous medical devices that help uplift and save people’s lives such as corneal transplants and hip replacements, the film mostly focuses on some medical devices that have harmed people. Through this expose, the Netflix film provides shocking revelations regarding medical devices that are implanted in people’s bodies in attempts to enhance their health and wellbeing.

One of the medical devices discussed in this film is hip replacement, which has traditionally been a terrific medical device. This medical device is implanted in an individual’s body to help restore mobility and relieve pain brought by hip diseases or injuries like arthritis. However, the conventional hip replacement medical device has been improved to help enhance its effectiveness. The improvements have in turn been characterized by some side effects such as leakage of cobalt into people’s body, which in turn generates physical and...

...

The Bleeding Edge also discusses Essure, which is a contraceptive used for birth control. This medical device in inserted by an Essure trained doctor through the natural pathways of the body such as cervix and vagina into the fallopian tubes. Essure is associated with side effects of excruciating pain, which in turn contributes to difficulties in working due to complications. The other medical device mentioned in the movie is transvaginal mesh produced by Johnson and Johnson. This device is used for pelvic repairs through implanting into the vaginal wall. The side effects and potential harm of transvaginal mesh include pelvic pain, bleeding, organ perforation, and pain during sexual intercourse.
The film indicates how the system for approving medical devices in the United States is relatively flawed. The first step in this process is pre-market approval (PMA) in which device manufacturers are required by federal law to give a notice of intent to the U.S. Food and Drug Administration at least 90 days before marketing (Van Norman, 2016). PMA is the strictest device marketing application that is required by this agency for any new medical device before it enters the market. PMA is significant in this process since it’s used to demonstrate…

Sources Used in Documents:

References



Dick, K. (Director). (2018). The Bleeding Edge [Motion picture]. USA: Netflix.



Gleiberman, O. (2018, July 27). Film Review: ‘The Bleeding Edge.’ Retrieved February 11, 2019, from https://variety.com/2018/film/reviews/the-bleeding-edge-review-kirby-dick-1202887859/



Van Norman, G.A. (2016, June). Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices. JACC: Basic to Translational Science, 1(4), 277-287.



Cite this Document:

"New Medical Devices In The Market" (2019, February 11) Retrieved April 29, 2024, from
https://www.paperdue.com/essay/new-medical-devices-in-market-essay-2173276

"New Medical Devices In The Market" 11 February 2019. Web.29 April. 2024. <
https://www.paperdue.com/essay/new-medical-devices-in-market-essay-2173276>

"New Medical Devices In The Market", 11 February 2019, Accessed.29 April. 2024,
https://www.paperdue.com/essay/new-medical-devices-in-market-essay-2173276

Related Documents

Requirements and Design - This focuses on the areas of intricacies of turning functional specifications into technical specifications, and also creating a series of approaches to giving users a chance to see the development of applications and most importantly, giving them the chance to review evolving system functionality. Approval and Gate Process - This is the critical step where ownership by users is tested, as the evolving functionality and direction of

Porters Australia Porters Five Forces Analysis of Medical Devices in Australia Threat of New Competition -- Medium The threat of new competition in the medical devices industry is believed to be at a medium level. This is primarily due to the fact that this industry is heavily regulated and must comply with legislation such as the Therapeutic Goods Act of 1989 (Department of Health and Ageing, 2011). The regulatory environment acts as a

Selecting the best country to locate off-shore manufacturing operations can be a difficult decision owing to the complexities involved in global supply chain operations. The various available options must be carefully evaluated if the desired outcomes are to be successfully achieved. With manufacturing costs in New Zealand on the rise, Kiwi must select a country that offers more competitive costs combined with an acceptable level of risk. Of the four

Market Model Changes The medtech, or medical technology, industry is a large and intensely competitive industry that produces highly innovative medical devices for hospitals and other healthcare facilities in the effort to save lives and improve health for patients (Research, 2012). It is spread across different segments including, cardiology, oncology, neuro, orthopedic, and aesthetic devices. It relies largely on aging baby boomers, high unmet medical needs, and increased incidence of lifestyle

Medical Technology Medical Imaging Technology in an information driven world Technology and technology applications in the medical fields are proliferating faster than proverbial rabbits. The advances in digital transmission of data, together with application of MRI technology and micro circuitry have created opportunities for the medical profession to gain more accurate information, analysis, and prognoses than ever before. MRI machines produce images which are clearer, and virtually three dimensional for the medical

Initial product formulation utilizes knowledge acquired from pre-formulation outcomes to derive proper dose, dosage form, and type of administration for the proposed marketed use. A pilot batch of Clinical Trial Materials (CTM) may be produced after the new drug has completed these initial tests. Upon completion of preclinical testing, the drug sponsor files an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA), after they have